These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 15660271

  • 1. Continuing clozapine treatment despite neutropenia.
    Esposito D, Rouillon F, Limosin F.
    Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
    [Abstract] [Full Text] [Related]

  • 2. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L, Cazard F.
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [Abstract] [Full Text] [Related]

  • 3. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M, Gochman P, Rapoport JL.
    J Child Adolesc Psychopharmacol; 2003 Aug; 13(3):401-4. PubMed ID: 14642024
    [Abstract] [Full Text] [Related]

  • 4. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P, Slater S, Measham T, Koch M, Wiviott G.
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [Abstract] [Full Text] [Related]

  • 5. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
    Ahn YM, Jeong SH, Jang HS, Koo YJ, Kang UG, Lee KY, Kim YS.
    Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of clozapine-induced granulocytopenia with lithium (two observations)].
    Papetti F, Darcourt G, Giordana JY, Spreux A, Thauby S, Feral F, Pringuey D.
    Encephale; 2004 Mar; 30(6):578-82. PubMed ID: 15738861
    [Abstract] [Full Text] [Related]

  • 7. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP.
    Tijdschr Psychiatr; 2007 Mar; 49(8):575-9. PubMed ID: 17694491
    [Abstract] [Full Text] [Related]

  • 8. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R, Subhalakshmi TP, Kuruvilla A, Jacob KS.
    J Postgrad Med; 2013 Mar; 59(1):54-5. PubMed ID: 23525060
    [Abstract] [Full Text] [Related]

  • 9. [A case study; ethnicity and clozapine, a risky combination?].
    Laan WJ, Ramlal D.
    Tijdschr Psychiatr; 2012 Mar; 54(9):829-33. PubMed ID: 22961282
    [Abstract] [Full Text] [Related]

  • 10. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    BMC Psychiatry; 2016 Dec 12; 16(1):441. PubMed ID: 27955666
    [Abstract] [Full Text] [Related]

  • 11. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG, Stewart JT.
    South Med J; 2008 Jun 12; 101(6):639-40. PubMed ID: 18475227
    [Abstract] [Full Text] [Related]

  • 12. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL, Yim PH.
    East Asian Arch Psychiatry; 2015 Dec 12; 25(4):164-7. PubMed ID: 26764291
    [Abstract] [Full Text] [Related]

  • 13. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N, Myles H, Clark SR, Bird R, Siskind D.
    Aust N Z J Psychiatry; 2017 Oct 12; 51(10):980-989. PubMed ID: 28747065
    [Abstract] [Full Text] [Related]

  • 14. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
    Lally J, Malik S, Krivoy A, Whiskey E, Taylor DM, Gaughran FP, Flanagan RJ, Mijovic A, MacCabe JH.
    J Clin Psychopharmacol; 2017 Oct 12; 37(5):600-604. PubMed ID: 28817489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
    Corbeil O, Béchard L, Fournier É, Plante M, Thivierge MA, Lafrenière CÉ, Huot-Lavoie M, Brodeur S, Essiambre AM, Roy MA, Demers MF.
    J Psychopharmacol; 2023 Apr 12; 37(4):370-377. PubMed ID: 36794520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.